Bioiberica S.A.U., headquartered in Spain, is a leading player in the biotechnology and pharmaceutical industry, specialising in the development of innovative solutions for human and animal health. Founded in 1986, the company has established a strong presence in Europe and beyond, focusing on areas such as joint health, nutraceuticals, and biopharmaceuticals. With a commitment to research and development, Bioiberica offers a range of unique products, including high-quality ingredients derived from natural sources. Their flagship offerings, such as glucosamine and hyaluronic acid, are renowned for their efficacy and safety, setting them apart in a competitive market. Recognised for its dedication to quality and sustainability, Bioiberica has achieved significant milestones, positioning itself as a trusted partner in the health sector. The company continues to innovate, contributing to advancements in health and wellness globally.
How does Bioiberica Sau's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Bioiberica Sau's score of 3 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Bioiberica Sau, headquartered in Spain, has not publicly disclosed specific carbon emissions data for the most recent year. However, the company is committed to reducing its carbon footprint and has set near-term reduction targets. As of February 2023, Bioiberica Sau is classified as "Committed" to these targets, indicating a proactive approach to addressing climate change within the pharmaceuticals, biotechnology, and life sciences sector. While the company has not established a net-zero commitment or specified long-term targets, it is actively working towards measurable reductions in its emissions. The absence of detailed emissions figures suggests that Bioiberica Sau is in the process of developing its climate strategy and may be focusing on enhancing its sustainability practices. In summary, Bioiberica Sau is taking steps to address its climate impact through committed reduction initiatives, although specific emissions data and detailed targets are currently unavailable.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Bioiberica Sau is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.